New Delhi: The World Health Organization is likely to arrive at the Covaxin Authorization Decree, Covid-19 Vaccine Bharat Biotech, next month.
Hansel Mariangela Simao, an assistant General of the WHO assistant for the vaccine, said the UN health agency assessment of the “advanced” vaccine and officials hoped for the decision in mid-September.
Made-in-India Covaxin has been authorized for emergency use in India, and has also been exported to several countries.
But it has not been authorized by the Western Supervisory Authority.
Indian scientists said this vaccine was around 78% effective, but some data from further research was still awaited.
Ocugen, US and Canada Bharat Biotech partners for Covaxin, said they have sent all data to the Canadian government and are under an active review of the health regulator there.
It has approached Canadian health and submitted data clinical clinical test data 3 of Covaxin which was looking for authorization to sell Jab in the country.
Who authorizes for Covaxin will come as aid for India inoculated with vaccines and international travel planning.
(With agency input)